SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) -- Ignore unavailable to you. Want to Upgrade?


To: Stephen M. DeMoss who wrote (260)4/25/2002 9:28:02 PM
From: John McCarthy  Read Replies (1) | Respond to of 371
 
3:03PM Immunomedics on rumors of a possible product delay (IMMU) 12.85 -2.75: Hearing trading floor talk that when Amgen (AMGN -0.52) reports earnings tonight, they may announce that trials on the drug they collaborate with IMMU on have been pushed out; IMMU officials declined to comment citing a confidentiality agreement with AMGN.

finance.yahoo.com

(Please do not respond to this post.)
John McCarthy